AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
OLOPATADINE HYDROCHLORIDE USP
7 registrations across 4 African markets— 5 active
Markets with OLOPATADINE HYDROCHLORIDE USP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Olpadin DS Ophthalmic Solution Ophthalmic Solution | 🇰🇪Kenya | Aristopharma Ltd. | active | Dec 2030 |
| Olpadin Ophthalmic Solution Ophthalmic Solution | 🇰🇪Kenya | Aristopharma Ltd. | active | Dec 2030 |
| Olopat OD Ophthalmic | 🇷🇼Rwanda | Ajanta Pharma Limited | active | Aug 2029 |
| OLOGIC Eye Drops, Solution | 🇰🇪Kenya | Aurolab | active | Nov 2028 |
| OLAPO EYE DROPS Eye Drops, Solution | 🇰🇪Kenya | GALAXY PHARMACEUTICAL LTD | active | Nov 2027 |
| KATANOL EYE DROP | 🇳🇬Nigeria | KAYHELT PHARMA LTD. 2 | expired | Feb 2023 |
| NEOLAP 0.2%W/V EYE DROPS EYE DROPS | 🇲🇼Malawi | — | expired | Jun 2016 |
OLOPATADINE HYDROCHLORIDE USP in Africa — Regulatory Overview
OLOPATADINE HYDROCHLORIDE USP is registered across 4 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Kenya, Malawi, Nigeria, Rwanda. AfricaRegulatory refreshes this data daily from official government sources.
Of the 7 registrations, 5 (71%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.